A new study suggests that an epilepsy drug could help alleviate symptoms of obstructive sleep apnoea, a common condition affecting about 5% of people.
Presented at the European Respiratory Society Congress in Vienna, the research indicates that the drug sulthiame may significantly reduce breathing interruptions and improve oxygen levels during sleep.
Obstructive sleep apnoea, which causes frequent interruptions in breathing during sleep, is often treated with mechanical devices like CPAP machines.
However, many patients struggle with these devices, prompting the search for alternative treatments.
The international study involved nearly 300 patients across Belgium, the Czech Republic, France, Germany, and Spain, who were either given sulthiame at varying doses or a placebo.
After 12 weeks, those on sulthiame experienced up to 50% fewer breathing pauses and higher blood oxygen levels compared to those on the placebo. The most significant benefits were observed with the highest doses of the drug.
Source:
Oman News Agency
